Related Experiment Video
Updated: Jul 8, 2026
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
OM-89 modulation of chronic inflammation: relevance to clinical use
D Willis1, A R Moore, G Gowland
1Department of Experimental Pathology, St Bartholomew's Hospital Medical College, London.
Abstract:
The modulatory effects of a glycoprotein-rich endotoxin-free extract of Escherichia coli (OM-89) have been studied using the cotton pellet model of chronic inflammation in the male Wistar rat. OM-89 had a suppressive effect on the size of granuloma surrounding implanted cotton pellets at both 4 and 40 mg/kg given three times weekly. The lower dosage of 4 mg was effective throughout and there was little to be gained by increasing the dose as further reduction of granuloma size was not obtained. Whether given prior to, at the same time as, or after an inflammatory stimulus, OM-89 had suppressive effects. However, if given before, animals at first went through a phase of 'sensitization' before suppressive effects were seen on further exposure to OM-89 antigens, a phenomenon which might have bearing on clinical findings in rheumatoid arthritis. In animals presensitized to a cotton pellet, OM-89 was statistically as effective as indomethacin in suppressing a second granuloma. OM-89 combined with indomethacin showed additive effects and was highly effective. The results indicate that OM-89 could be efficacious in the treatment of chronic inflammatory conditions and there is the possibility that in appropriate circumstances OM-89 might replace some drugs currently used and in others reduce their dosage.
Insights
Escherichia coli (OM-89) extract suppressed chronic inflammation in rats. This endotoxin-free glycoprotein extract showed efficacy comparable to indomethacin, suggesting potential for treating inflammatory conditions.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Chronic inflammation is a significant health concern.
- Current treatments for chronic inflammatory conditions have limitations.
- Escherichia coli (OM-89) extract is a glycoprotein-rich, endotoxin-free preparation.
Purpose of the Study:
- To investigate the modulatory effects of OM-89 on chronic inflammation.
- To evaluate OM-89's efficacy in a rat model of inflammation.
- To compare OM-89's effects with indomethacin and assess combination therapy.
Main Methods:
- Cotton pellet model of chronic inflammation in male Wistar rats.
- Administration of OM-89 at 4 and 40 mg/kg doses, three times weekly.
- Assessment of granuloma size as a measure of inflammation.
- Comparison with indomethacin and evaluation of combined therapy.
Main Results:
- OM-89 significantly suppressed granuloma formation at both 4 and 40 mg/kg.
- The 4 mg/kg dose was effective, with no additional benefit from higher doses.
- OM-89 demonstrated suppressive effects regardless of timing relative to the inflammatory stimulus.
- OM-89 showed comparable efficacy to indomethacin in presensitized animals.
- Combination therapy with OM-89 and indomethacin exhibited additive effects.
Conclusions:
- OM-89 exhibits significant anti-inflammatory properties in a chronic inflammation model.
- OM-89 shows potential as a therapeutic agent for chronic inflammatory conditions.
- OM-89 may offer an alternative or adjunctive treatment, potentially reducing the dosage of existing drugs.
More Related Videos
Related Concept Videos
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:12Chronic Inflammation: Introduction
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:25Inflammatory Bowel Disease III: Crohn's Disease